Video Experimental Relacionado
Updated: Aug 9, 2026
10:00
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
La inhibición del metabolismo de la teofilina por el interferón
S J Williams1, J A Baird-Lambert, G C Farrell
1Department of Medicine, University of Sydney, NSW, Australia.
Lancet (London, England)
|October 24, 1987
Resumen
El interferón alfa A recombinante redujo significativamente el aclaramiento de teofilina en pacientes con hepatitis B crónicamente activa y en individuos sanos. Esto sugiere que el interferón puede afectar el metabolismo de los medicamentos y conducir a interacciones farmacológicas.
Área de la Ciencia:
- Farmacología Farmacología.
- Hepatología Hepatología.
- Inmunología Inmunología.
Sus antecedentes:
- Las interferonas son citoquinas con diversos efectos biológicos, incluida la modulación inmune.
- El metabolismo hepático de los fármacos es crucial para la eficacia y seguridad de los fármacos.
- La hepatitis B crónica activa puede afectar la función hepática y el procesamiento de medicamentos.
Objetivo del estudio:
- Para investigar el efecto del interferón humano recombinante alfa A en la farmacocinética de la teofilina.
- Para explorar la relación entre el efecto del interferón y el metabolismo basal de la teofilina.
- Para evaluar el potencial de interacciones medicamentosas inducidas por el interferón.
Principales métodos:
- Se administró una sola inyección intramuscular de interferón humano recombinante alfa A.
- El aclaramiento de la teofilina y la vida media de eliminación se midieron en 5 pacientes con hepatitis B crónicamente activa y 4 controles sanos.
- Se compararon los parámetros farmacocinéticos antes y después del tratamiento.
Principales resultados:
- El aclaramiento de teofilina se redujo significativamente 1 día después de la administración de interferón.
- La semivida de eliminación de la teofilina aumentó significativamente después de la interferona.
- El efecto del interferón fue más pronunciado en individuos que eran metabolizadores rápidos de la teofilina.
Conclusiones:
- El interferón alfa A recombinante altera la farmacocinética de la teofilina, reduciendo su aclaramiento y aumentando su semivida.
- El interferón endógeno puede contribuir a alterar el metabolismo hepático de los fármacos observado durante infecciones virales o inmunizaciones.
- La terapia con interferón conlleva un riesgo de interacciones farmacológicas clínicamente significativas, particularmente con medicamentos metabolizados por el hígado.
Videos de Conceptos Relacionados
01:24Antiasthma Drugs: Methylxanthines
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...